US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
Tuesday, April 30th 2024, 5:24:15 pm
article
The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic
Breaking
U.S. and Israeli strikes on Iran are not just a military conflict but an attempt to force a regional realignment of incentives, argues this analysis of Trump's Middle East strategy....
StraitsX, a Singapore-based company, has seen rapid growth in its stablecoin card program, with a 40x surge in transaction volume and an 83x increase in card issuance between 2024 and 2025....
